Acute renal failure and nephrotic syndrome associated with zafirlukast therapy.
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy; D001707:Biopsy, Needle; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007211:Indoles; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D048448:Phenylcarbamates; D011239:Prednisolone / Q000008:administration & dosage; D018570:Risk Assessment; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D018927:Anti-Asthmatic Agents; D007211:Indoles; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds; D011239:Prednisolone; C062735:zafirlukast